Skip to main content

Table 3 Univariate analysis for postoperative prognostic factors in cause-specific survival of patients with invasive pancreatic neoplasms after repeat pancreatectomy

From: Long-term outcomes and significance of preoperative lymphocyte-to-monocyte ratio as a prognostic indicator in patients with invasive pancreatic neoplasms after repeat pancreatectomy

Clinico-pathological parameters

Univariate analysis

n = 28

HR (95% CI)

p value

Diagnosis at RP (PC/invasive IPMC)

24 / 4

1.88 (0.37–34.26)

0.51

Operation method (PD/DP)

8 / 20

1.56 (0.42–4.84)

0.48

PVR (+/−)

4 / 24

6.90 (1.39–28.83)

0.021*

Arterial resection (+/−)

5 / 23

4.28 (1.10–14.56)

0.037*

pT (I / II,III,IV)

8 / 20

0.68 (0.15–2.24)

0.55

pN (+/−)

12 / 16

5.06 (1.59–19.31)

0.0057*

Curability (R0/1)

21 / 7

1.11 (0.34–4.94)

0.88

C-D (≤ IIb/≥ IIIa)

23 / 5

0.40 (0.12–1.79)

0.20

Postoperative CA19–9 levels (≥ 37/<  37) (U/mL)

11 / 17

1.81 (0.58–5.46)

0.30

Decrease rate of CA19–9 (≥ 70/<  70) (%)

14 / 14

0.35 (0.09–1.09)

0.067

Adjuvant chemotherapy after RP (+/−)

17 / 11

1.35 (0.43–5.05)

0.61

  1. n the number of participants, HR hazard ratio, CI confidence interval, PC pancreatic cancer, IPMC intra-papillary mucinous carcinoma, PD pancreaticoduodenectomy, DP distal pancreatectomy, PVR portal vein resection. *: significant value. C-D Clavien-Dindo classification, RP repeat pancreatectomy